Investor Presentaiton slide image

Investor Presentaiton

Erber Group's animal nutrition & health specialty businesses Sales by Region, FY19A1 (%) . • Privately held Austrian innovation-led company, founded in 1983. Biomin and Romer Labs together have: ✓ Combined sales of €330m and an Adjusted EBITDA margin above 20% for the twelve months to the end of March 2020 ~1,200 employees ✓ Global footprint with 12 production sites and 15 R&D sites ✓ Sales in 130 countries; Specialty sales force of ~200 people across 40 countries Sanphar and EFB (two very small divisions of Erber Group are not included in above numbers; will be carved out before closing) Leader in mycotoxin risk management solutions, as the pioneer in the field supported by scientific claims, strong position in gut health/ eubiotics as well as in premix and diagnostics for feed and food ✓ international focus and their in-house research and development department are key elements of their success and have contributed to growth & sustainability for more than 30 years ✓ Strong IP protection; patents and trade marks ✓ Long-standing global customer base with customized solutions for key accounts ROMER Romer Labs 6 1. Across acquired perimeter (Biomin and Romer only). Europe Asia North America South America Sales by Segment, FY19A1 (€m) =Tiomine Naturally ahead Mycotoxin risk mgmt Gut health/eubiotics Premix Other (trade) Food and feed testing (Romer Labs) DSM
View entire presentation